Clinical Trial Update: CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating genotype-guided selection of P2Y12 inhibitors after complex PCI in ACS patients with CYP2C19 polymorphism is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Zunyi Medical College | Conditions: ACS - Acute Coronary Syndrome, CYP2C19 Polymorphism | Phase 4 | Status: RECRUITING